Literature DB >> 24047558

Antigenic variation in African trypanosomes: the importance of chromosomal and nuclear context in VSG expression control.

Lucy Glover1, Sebastian Hutchinson, Sam Alsford, Richard McCulloch, Mark C Field, David Horn.   

Abstract

African trypanosomes are lethal human and animal parasites that use antigenic variation for evasion of host adaptive immunity. To facilitate antigenic variation, trypanosomes dedicate approximately one third of their nuclear genome, including many minichromosomes, and possibly all sub-telomeres, to variant surface glycoprotein (VSG) genes and associated sequences. Antigenic variation requires transcription of a single VSG by RNA polymerase I (Pol-I), with silencing of other VSGs, and periodic switching of the expressed gene, typically via DNA recombination with duplicative translocation of a new VSG to the active site. Thus, telomeric location, epigenetic controls and monoallelic transcription by Pol-I at an extranucleolar site are prominent features of VSGs and their expression, with telomeres, chromatin structure and nuclear organization all making vitally important contributions to monoallelic VSG expression control and switching. We discuss VSG transcription, recombination and replication control within this chromosomal and sub-nuclear context.
© 2013 The Authors. Cellular Microbiology published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24047558      PMCID: PMC3963442          DOI: 10.1111/cmi.12215

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


Introduction

Control of antigenic variation in pathogens is of interest for at least two major reasons. First, it is clearly an important immune evasion and virulence strategy, and second, it frequently requires monoallelic gene expression, a common mechanism also utilized by mammals, for our sense of smell, for example (Lyons et al., 2013). Many pathogenic protists express major and variable surface proteins one at a time for immune evasion, including Plasmodium falciparum, the malaria parasite (Guizetti and Scherf, 2013), Giardia, the cause of intestinal giardiasis (Prucca and Lujan, 2009), and Trypanosoma brucei, the tsetse-fly transmitted African trypanosome that causes sleeping sickness in humans and nagana in livestock. Our knowledge regarding mechanisms that silence all but one gene has improved recently. For example, an H3K36 histone methyltransferase, PfSETvs, is required for var gene silencing in P. falciparum (Jiang et al., 2013), RNA interference is required for VSP gene silencing in G. lamblia (Prucca et al., 2008) and the telomere-binding protein RAP1 is required for VSG silencing in T. brucei (Yang et al., 2009). Our understanding of the mechanisms selecting a single gene for activation is less advanced. Location is important, and for VSGs, both the chromosomal location (Fig. 1) and position within the nucleus (Fig. 2) appear to be critical. In addition, transcription states and chromatin states frequently go hand-in-hand with nuclear position; typically, silent, condensed chromatin occupies peripheral ‘heterochromatic’ space. Sub-telomeres in many organisms are populated with contingency genes, which are often only expressed when needed, and these regions tend to conform to this heterochromatic paradigm. However, in monoallelic expression systems a single active gene escapes the silent heterochromatin. In the case of T. brucei VSGs, the escapee is transcribed at a telomere by RNA polymerase I (Pol-I) (Gunzl et al., 2003). This single VSG, rather than associating with Pol-I at the nucleolus as previously suspected, is held at a distinct extranucleolar site (Chaves et al., 1998; Navarro and Gull, 2001). DNA recombination and nuclear dynamics are also important here since VSGs can be translocated to the active site to bring about a VSG switch, clearly requiring intimate interactions with the silent archive (Fig. 1B). Transcription can also switch from one telomeric VSG to another telomeric VSG. Here we focus on VSG gene control in African trypanosomes, considering both cis-acting sequences and trans-acting factors, how they behave in the context of telomeric chromatin and nuclear positioning and how they control VSG expression, recombination and replication.
Figure 1

The chromosomal context of VSG genes.A. The schematic shows how up to 2000 VSG genes and VSG pseudo-genes occupy the subtelomeres of three different classes of T. brucei chromosomes: megabase, up to 6 Mbp; intermediate, 150–500 kbp; mini, 50–100 kbp. Repetitive sequences found at these loci are thought to be important for monoallelic VSG expression control and for VSG switching via DNA double-strand break (DSB) repair. Telomeric T2AG3-repeats cap all T. brucei chromosomes. Megabase chromosomes are diploid with hemizygous sub-telomeres. Bloodstream expression site (BES) promoters, ESAGs and metacyclic expression sites are not shown.B. Mechanisms of antigenic variation; switching from VSG1 to VSG2. Telomere-proximity is thought to render the active VSG locus prone to DSBs. The 70 bp repeats then facilitate gene conversion, replacement of the active VSG with a VSG (or VSG segment) copied from any one of multiple alternative locations. Monoallelic VSG expression is also maintained during an in-situ transcription switch. Only the relevant portions of the BESs are shown.

Figure 2

Nuclear sub-compartments in trypanosomes. A procyclic and bloodstream form nucleus is shown, with the region of heterochromatin (corresponding to ∼ 15% of nuclear volume) in light gray. The nucleolus is shown as a dark gray structure within the nucleus, and in the procyclic form is associated with the procyclin loci (purple). Nuclear pore complexes are shown as double lozenges, and the nuclear lamina as a thin blue lines within the region of heterochromatin. Inactive VSG expression sites are red and located at the nuclear periphery, while the active locus is in green, and is equivalent to the expression site body (ESB). The major changes are that the procyclin loci are downregulated in the bloodstream form and likely come to reside within the heterochromatin, while a single VSG expression site associates with the ESB. While morphologically there may be differences in heterochromatin, evidence is consistent with peripheral chromatin bearing inactive genes in both life cycle stages.

The chromosomal context of VSG genes.A. The schematic shows how up to 2000 VSG genes and VSG pseudo-genes occupy the subtelomeres of three different classes of T. brucei chromosomes: megabase, up to 6 Mbp; intermediate, 150–500 kbp; mini, 50–100 kbp. Repetitive sequences found at these loci are thought to be important for monoallelic VSG expression control and for VSG switching via DNA double-strand break (DSB) repair. Telomeric T2AG3-repeats cap all T. brucei chromosomes. Megabase chromosomes are diploid with hemizygous sub-telomeres. Bloodstream expression site (BES) promoters, ESAGs and metacyclic expression sites are not shown.B. Mechanisms of antigenic variation; switching from VSG1 to VSG2. Telomere-proximity is thought to render the active VSG locus prone to DSBs. The 70 bp repeats then facilitate gene conversion, replacement of the active VSG with a VSG (or VSG segment) copied from any one of multiple alternative locations. Monoallelic VSG expression is also maintained during an in-situ transcription switch. Only the relevant portions of the BESs are shown. Nuclear sub-compartments in trypanosomes. A procyclic and bloodstream form nucleus is shown, with the region of heterochromatin (corresponding to ∼ 15% of nuclear volume) in light gray. The nucleolus is shown as a dark gray structure within the nucleus, and in the procyclic form is associated with the procyclin loci (purple). Nuclear pore complexes are shown as double lozenges, and the nuclear lamina as a thin blue lines within the region of heterochromatin. Inactive VSG expression sites are red and located at the nuclear periphery, while the active locus is in green, and is equivalent to the expression site body (ESB). The major changes are that the procyclin loci are downregulated in the bloodstream form and likely come to reside within the heterochromatin, while a single VSG expression site associates with the ESB. While morphologically there may be differences in heterochromatin, evidence is consistent with peripheral chromatin bearing inactive genes in both life cycle stages.

The telomeric VSG environment

The T. brucei silent VSG archive is located at sub-telomeric loci, with most genes in silent arrays and many VSGs immediately adjacent to the telomeres of the megabase, intermediate and minichromosomes (Fig. 1A). The single expressed VSG is invariably located immediately adjacent to a telomere in a bloodstream-form expression site (BES) on one of the larger chromosomes (Marcello and Barry, 2007). VSG switching is thought to occur with a frequency of 10−2/mitotic division. This can decrease ∼ 1000-fold during growth in culture or passage in rodents but returns to the higher rate after passage through the tsetse-fly vector (Turner, 1997), possibly due to erasure of a DNA or chromatin modification (see below). In common with the core T. brucei transcriptome, the active BES is transcribed as a polycistronic unit and individual mRNAs are generated by co-transcriptional trans-splicing. Unlike most of the genome, however, the BES is transcribed by Pol-I (Gunzl et al., 2003). Metacyclic VSGs, which normally drive expression of the VSG coat in cells in the tsetse-fly salivary glands, are also transcribed by Pol-I at telomeres, but these VSGs are found in monocistronic units (Pedram and Donelson, 1999; Kolev et al., 2012). Analysis of 15 T. brucei BESs revealed striking similarities, both in sequence and structure (Hertz-Fowler et al., 2008). Functional BESs have a telomere-distal RNA Pol-I promoter, an array of ES-associated genes (ESAGs) with largely conserved synteny and two promoter-proximal genes (ESAG6 and ESAG7) that encode a novel transferrin receptor (Steverding et al., 1994). Many BESs also contain ESAG and VSG pseudogenes. Indeed, several BESs lack specific functional ESAGs and have not been activated in vitro, suggesting that a minimum set of ESAGs are required for growth. BES VSGs are separated from the ESAGs by a block of 70 bp repeats and are always adjacent (200–1600 nt spacing) to the telomere repeats (Fig. 1A). The T. brucei telomere comprises T2AG3-repeats (as also found in humans) of up to ∼ 15 kbp (Horn et al., 2000; Dreesen et al., 2007) with terminal t-loop structures of ∼ 1 kbp (Munoz-Jordan et al., 2001). Telomeres are maintained and extended indefinitely by telomerase reverse transcriptase (TERT) (Dreesen et al., 2005; Glover et al., 2007), a nucleo-protein complex with an RNA template sequence (Sandhu et al., 2013). The transcribed telomere associated with the active BES is extended most rapidly (Horn et al., 2000) but may be prone to frequent breaks (Bernards et al., 1983; Pays et al., 2013; Horn and Cross, 1997). In TERT-null mutants, telomere length decreases and, when the length becomes very short (7–27 repeats), TERT-independent stabilization occurs (Dreesen and Cross, 2006a). In these circumstances, the TERT-null mutants display elevated VSG switching driven by gene conversion (Dreesen and Cross, 2006b; Hovel-Miner et al., 2012). It has also been observed that recently isolated strains, thought to switch at a high frequency, have shorter telomeres than observed in the most widely studied ‘slow-switching’ populations (Dreesen and Cross, 2008). A direct test of whether telomere length impacts VSG switching in wild-type cells is challenging and has yet to be reported, however. The T. brucei telomere-associated protein complex resembles that described in mammals and yeast, and characterization of the associated factors has yielded important insights into VSG expression control. Unexpectedly, many telomere-associated proteins have little impact on VSG silencing, including the telomere length regulator Ku70/Ku80 (Conway et al., 2002a), the histone H3 variant (Lowell and Cross, 2004), the telomere repeat-binding protein TRF2 (Li et al., 2005) or the silent-information regulator SIR2rp1 (Alsford et al., 2007). In contrast, RAP1, an essential component of the telomere complex, does play a role in repression of BES VSGs (Yang et al., 2009). However, further analysis of RAP1-mediated repression showed a more pronounced effect in insect-stage cells and a measurable impact on chromatin structure only in this life cycle stage (Pandya et al., 2013). In addition, although telomeres do silence Pol-I transcribed genes in bloodstream-stage T. brucei, this effect was restricted to only a few kilobases (Glover and Horn, 2006), and telomere loss at a silent BES fails to derepress that BES (Glover et al., 2007). Thus, although current findings support the idea that the telomeric environment is important for VSG expression control, with a conserved telomeric silencing mechanism operating in T. brucei, as also observed in budding yeast (Pryde and Louis, 1999), additional mechanisms likely contribute to VSG silencing in the context of a monoallelic expression system.

The nucleolus, the ESB and the nuclear periphery

In common with most eukaryotic cells, the trypanosome nucleus is subdivided internally. These intranuclear compartments were originally described by ultrastructure and differential electron density, and while the nucleus is now known to possess multiple domains or compartments, the nucleolus, nuclear envelope and differentiation between high and low electron dense hetero-and euchromatin clearly also applies to trypanosomes (Vickerman and Preston, 1970; Rout and Field, 2001). The nucleolus in trypanosomes, as in other eukaryotes, is the site of rRNA transcription and ribosome assembly. Indeed, the nucleolus is rapidly disassembled and morphologically lost following inhibition of transcription with actinomycin D (Nazer and Sanchez, 2011). In trypanosomes, the nucleolus also serves as a location for transcription of the procyclin locus (Landeira and Navarro, 2007), encoding the superabundant procyclin antigens at the surface of insect, midgut-stage cells (Roditi et al., 1987) (Fig. 2). This location can be rationalized by the need for Pol-I mediated procyclin transcription, and the polymerase involved is apparently identical to the Pol-I involved in rRNA transcription (Gunzl et al., 2003). By direct visualization, procyclin genes localize at the nucleolar periphery in procyclic stages (Landeira and Navarro, 2007). Significantly, this peripheral location is also the site of most transcriptional activity as detected by BrUTP-labelling. While formal determination of the location of the procyclin locus in bloodstream cells is lacking, its absence from the nucleolar periphery and incorporation into peripheral heterochromatin can be inferred by derepression following knockdown of the lamina protein NUP-1 (DuBois et al., 2012). An apparently unique feature of African trypanosomes is the presence of a developmentally regulated extranucleolar Pol-I containing focus; on account of association with the active VSG BES, this structure is called the ES body (ESB) (Navarro and Gull, 2001). The ESB contains only the active BES, while inactive BESs, and hence VSGs, presumably occupy a more peripheral heterochromatin compartment (Fig. 2). The ESB is present at all cell-cycle stages in bloodstream-form cells but has never been observed in the insect stage. Indeed, during in vitro differentiation, the ESB is lost and the active BES relocates to the nuclear periphery (Landeira and Navarro, 2007). ESB replication/separation is a somewhat late event in mitosis and is important for the stable inheritance of VSG expression status; the ESB remains as a single structure into G2 and separates later than the rRNA genes or the inactive BESs (Landeira et al., 2009). When the ESB does segregate into each daughter nucleus, this inheritance requires cohesion, as knockdown of cohesin subunits leads to an increase in switching frequency among BESs (Landeira et al., 2009). The nuclear envelope provides a boundary for the separation of nuclear and cytoplasmic functions, and also a platform for organizing the nuclear interior. Organizing structures include the nuclear pore complex (NPC), the SUN/KASH domain proteins or LINC complex, a large disparate group of spectrin-repeat-containing proteins called Nesprins (Rajgor and Shanahan, 2013), plus the nuclear lamina. The level of conservation of these features between trypanosomes and mammals is remarkably variable. The NPC appears rather well conserved, at least in terms of overall composition (DeGrasse et al., 2009), but the LINC complex appears to be absent and there is little evidence for conservation of the other nesprins (Field et al., 2012). The lamina is also divergent, so that the 60 kDa intermediate filament proteins of mammals, lamins, are replaced in trypanosomes by a giant, repetitive protein, NUP-1, which is likely a component of fibres at the nuclear envelope (Rout and Field, 2001; DuBois et al., 2012). NUP-1 is a major structural protein which seems to assume many of the functions described for lamins in mammals, encompassing structural integrity of the nucleus, NPC positioning and regulation of gene expression. Significantly, knockdown of NUP-1 leads to derepression of inactive BESs, suggesting that the inactive BESs are indeed within heterochromatin, and that NUP-1 acts as an organizer of this region of the nucleus.

Chromatin and VSG expression control

The T. brucei histones are divergent with respect to the highly conserved histones of yeasts and metazoans (Alsford and Horn, 2004) and this is particularly true of their N-terminal tails. In spite of this divergence, multiple sites of acetylation and methylation on T. brucei histones have been identified (Janzen et al., 2006a; Mandava et al., 2007) and some of these, based on enrichment at probable transcription start-sites, have been implicated in the control of transcription by RNA Pol-II (Siegel et al., 2009; Wright et al., 2010). Trypanosomes also possess several histone variants, including H3V (Lowell and Cross, 2004), and a DNA base modification, J (β-d-glucosyl-hydroxymethyluracil), both enriched at telomeres (van Leeuwen et al., 1997). Many histone modifications have not yet been investigated in any detail but, at this stage, it remains possible that no histone N-terminal tail modification, nor any histone variant, nor base-J, play any major role in VSG expression control. Despite this, other aspects of chromatin structure and reversible histone modification do clearly contribute to the control of monoallelic VSG expression and antigenic variation in T. brucei (Figueiredo et al., 2009). Depletion of core nucleosomal histone H3 (Alsford and Horn, 2012) or ‘linker’ histone H1 (Povelones et al., 2012) results in derepression of silent BES promoters. A similar effect is also seen upon depletion of the histone chaperones, FACT (Denninger et al., 2010), NLP (Narayanan et al., 2011), ASF1A or CAF-1b (Alsford and Horn, 2012) and depletion of these chaperones results in different cell cycle defects, reflecting distinct DNA replication-dependent and-independent roles. Depletion of the chromatin remodeller, ISWI, also results in BES promoter derepression, and additionally causes some derepression of silent VSGs, though expression remains several orders of magnitude lower than seen at the active VSG BES (Stanne et al., 2011). Thus, reduction in the number of nucleosomes or changes in their organization at a repressed BES elicits some transcriptional derepression. These findings demonstrate an important role for chromatin in maintaining VSG silencing, and also suggest, as proposed earlier (Vanhamme et al., 2000), that transcription elongation rather than initiation is repressed. The location of VSG BESs proximal to telomeres suggested that classical sirtuin-dependent telomeric silencing might be involved in monoallelic VSG expression. However, though T. brucei SIR2rp1, HAT1 and DAC1 influence expression of telomere-proximal reporters, these factors appear to have little or no impact on VSG silencing (Alsford et al., 2007; Kawahara et al., 2008; Wang et al., 2010). Instead, two other histone modifying enzymes, DOT1B and DAC3, do impact BES transcription. DOT1B is a dispensable methyltransferase responsible for H3K79 tri-methylation (Janzen et al., 2006b), loss of which leads to partial derepression of silent VSGs and a significant slowing in switching between BESs (Figueiredo et al., 2008). Depletion of DAC3, an acetyltransferase with unknown target(s), results in reporter gene expression from a silent BES promoter, again with no detectable expression of the distal VSG (Wang et al., 2010). The active BES escapes repression and is depleted of nucleosomes (Figueiredo and Cross, 2010; Stanne and Rudenko, 2010), but it is unclear whether this is cause or consequence of Pol-I transcription. TDP1, a high mobility group protein, is enriched at actively transcribed Pol-I loci in T. brucei, and its depletion results in reduced transcription from rDNA loci and the active BES (Narayanan and Rudenko, 2013). These findings led to the hypothesis that TDP1 replaces histones in regions transcribed by Pol-I, thereby maintaining an open chromatin conformation that is amenable to transcription. T. brucei ELP3b, a putative acetyltransferase component of the so-called elongator complex, localizes specifically to the nucleolus and attenuates transcription at rRNA loci (Alsford and Horn, 2011). To date, no factor that localizes specifically to the ESB has been reported, however, so we do not fully understand the differences between Pol-I transcription in the ESB and in the nucleolus.

DNA double-strand-break repair and the telomeric environment

Central to antigenic variation is the ability of T. brucei to switch the active VSG, most commonly by gene conversion (Robinson et al., 1999), which requires the conserved DNA repair pathway of homologous recombination (HR). BES VSGs are flanked on the telomere distal-side by long stretches of 70 bp repeats, while most archival VSGs are flanked by short stretches of similar repeats (Fig. 1); it is these sequences that most frequently mediate VSG recombination (Marcello and Barry, 2007). Telomeric (including minichromosomal) VSGs predominate as silent donor sequences (Robinson et al., 1999) due to greater availability of flanking homologous sequences (Morrison et al., 2005). Most likely this explains why ESAGs and other BES sequences can also be exchanged via recombination elsewhere in the BES (Hertz-Fowler et al., 2008; Boothroyd et al., 2009). However, later in an infection, when the telomeric VSG archive is exhausted, subtelomeric array VSGs come to predominate, with segmental VSG conversion producing novel mosaic VSGs (Hall et al., 2013). Facilitating studies on HR in T. brucei, the yeast meganuclease, I-SceI, has been used to introduce single, locus-specific DNA double-strand breaks (DSBs) (Glover et al., 2008). At a chromosome-internal locus, these breaks trigger accumulation of RAD51 foci, a G2/M DNA-damage checkpoint and repair predominantly by HR (Glover et al., 2008). In addition, I-SceI mediated breaks at the active BES (upstream of the VSG and adjacent to the 70 bp repeats) trigger VSG switching, suggesting that these breaks mimic the natural triggers for switching (Boothroyd et al., 2009; Glover et al., 2013). In this case, a break-induced replication mechanism was observed, involving recombination initiated at the 70 bp repeats and duplication of the donor locus to the chromosome end (Boothroyd et al., 2009). Notably, BESs display a higher frequency of double-strand breaks relative to a chromosome-internal locus (Glover et al., 2013) suggesting that T. brucei telomeres render adjacent loci ‘fragile’. As observed at a chromosome-internal locus, I-SceI mediated DSBs adjacent to the 70 bp repeats at active BESs also trigger a ‘classic’ DSB response with DNA resection, accumulation of γH2A and evidence for a G2/M checkpoint (Glover et al., 2013); γH2A is histone H2A or a variant phosphorylated close to its C-terminus, and the altered chromatin structure associated with γH2A-foci is thought to facilitate repair (Glover and Horn, 2012). Surprisingly, a break immediately adjacent to telomeric repeats fails to trigger the G2/M checkpoint and often led to BES deletion. Similarly deprotected telomeres have also recently been shown to fail to contribute to the G2/M checkpoint in mammalian cells (Cesare et al., 2013) and this may reflect the presence of a distinct chromatin structure at telomeres. Taken together, these results indicate that the DSB response and frequency and mechanism of antigenic variation are highly dependent upon the position of a break within the BES (Glover et al., 2013). Fundamental to HR is Rad51, a homologous-strand exchange enzyme. T. brucei RAD51 (McCulloch and Barry, 1999) and a RAD51 paralogue, RAD51-3 (Proudfoot and McCulloch, 2005; Dobson et al., 2011), are important for HR, the DSB response and VSG switching. Knockout of the T. brucei orthologue of BRCA2, required to load RAD51 onto single-stranded DNA during repair, also reduces the VSG switching frequency to a level similar to that seen in RAD51 and RAD51-3 mutants (Hartley and McCulloch, 2008). In contrast, VSG gene conversion frequency increases in TOPO3α topoisomerase (Kim and Cross, 2010) and RMI1 mutants (Kim and Cross, 2011). These results suggest that a conserved TOPO3α-RMI1 complex, required to control mitotic crossover, promotes VSG switching via 70 bp repeat-initiated recombination, while reducing recombination elsewhere along the BES (Kim and Cross, 2010; 2011,). Compared with BRCA2 in other eukaryotes, T. brucei BRCA2 has undergone a striking expansion in the number of BRC repeats, the number of which correlates with the efficiency of HR and RAD51 loading (Hartley and McCulloch, 2008); this may facilitate antigenic variation and long-term immune evasion (Trenaman et al., 2013). Although RAD51-dependent mechanisms of VSG switching predominate, RAD51-independent mechanisms also operate (McCulloch and Barry, 1999). In T. brucei, microhomology-mediated end-joining (MMEJ) is the predominant RAD51-independent pathway, which uses 5–25 bp of imperfectly matched sequence to repair DSBs (Conway et al., 2002b; Glover et al., 2011). In other systems, non-homologous end-joining is the favoured Rad51-independent form of repair; however, T. brucei lacks key components of this pathway. Given the important role of tracts of imperfect 70 bp repeats in VSG recombination reactions (Fig. 1B), MMEJ could make an important contribution to VSG switching (Glover et al., 2011).

DNA replication and the heritability of VSG expression

A number of studies are providing insights into the machinery, co-ordination and regulation of T. brucei nuclear DNA replication and suggest a link with antigenic variation. The first link between the DNA replication machinery and VSG transcriptional control was based on studies of T. brucei ORC1/CDC6 (Godoy et al., 2009), a factor related to the Orc1 subunit of the conserved eukaryotic Origin Recognition Complex (ORC) and to Cdc6, which mediates ORC interaction with the replicative minichromosome maintenance (MCM) helicase. Knockdown of ORC1/CDC6 derepresses metacyclic VSGs in insect-stage cells (Tiengwe et al., 2012) and BESs in bloodstream-form cells and, to a lesser extent, BESs in insect-stage cells (Benmerzouga et al., 2013). Transient ORC1/CDC6 knockdown also increases BES switch frequency by approximately threefold (Benmerzouga et al., 2013). A genetic screen has revealed some loss of silencing at BESs in insect-stage cells and loss of silencing at BESs and procyclin loci in bloodstream-form cells following knockdown of MCM-binding protein (Kim et al., 2013). This factor appears to constitute a variant of the replicative MCM helicase, though a direct role in T. brucei replication has yet to be demonstrated. These findings implicate DNA replication in VSG transcriptional control, but the basis of this, and in particular whether there is a common mechanistic action of ORC1/CDC6 and MCM-binding protein, remains unclear. Association of ORC1/CDC6 with telomeres (Benmerzouga et al., 2013) may explain the observed effects, since Orc1 plays a role in gene silencing in yeast, P. falciparum and other organisms, both at telomeres and elsewhere (Sasaki and Gilbert, 2007). However, T. brucei ORC1/CDC6 is remarkably small relative to Orc1 orthologues and lacks the N-terminal bromo-adjacent homology domain involved in binding HP1, which acts in heterochromatin-mediated silencing in other organisms (Flueck et al., 2009; Perez-Toledo et al., 2009). Two less direct explanations for the roles of ORC1/CDC6 and perhaps MCM-binding protein in VSG expression are also possible. Loss of ORC1/CDC6 is likely to reduce the number of replication origins and hence replication efficiency, which in turn is likely signalled by the cell-cycle checkpoint machinery; in other eukaryotes ORC mutations trigger a Rad9-dependent checkpoint, arresting cells in S-phase (Ide et al., 2007). One genomic feature that Rad9 detects is methylation on H3K79, a modification catalysed by Dot1 (Nguyen and Zhang, 2011). In T. brucei, the equivalent histone residue, H3K76, is di-or tri-methylated by two enzymes, DOT1A and DOT1B, respectively (Janzen et al., 2006b). Although only DOT1A is linked to replication (Gassen et al., 2012), the alterations in VSG transcriptional control and VSG switching dynamics present in dot1b mutants, may be due to a link between replication and checkpoint signalling (Stockdale et al., 2008). Alternatively, the observed effects of the knockdowns on VSG expression and switching may relate to chromosome dynamics after replication. ORC in other eukaryotes is implicated in sister chromatid cohesion; pre-replication complexes can direct loading of cohesin, and ORC provides a cohesin-independent route for sister chromatid association in budding yeast (Diaz-Martinez et al., 2008). Thus, the effects of T. brucei cohesin knockdown, which also causes elevated BES switching (Landeira et al., 2009), may have a basis in interactions between sister chromatid cohesion and replication. Other studies also suggest that DNA replication acts in antigenic variation. The DNA DSBs found within the VSG BESs (Boothroyd et al., 2009; Glover et al., 2013) may form following replication stalling and replication-fork collapse. In addition, inheritance of the active and silent VSGs in their previously transcribed or silent states clearly depends upon the replication process. However, mechanistic data are currently lacking here, and we do not yet know the timing, rate or direction of replication through BESs or other VSG loci.

Conclusions

The available evidence indicates that VSG allelic exclusion and recombination, both essential aspects of antigenic variation in T. brucei, are critically dependent upon the telomeric environment. Emerging evidence also reinforces the importance of distinct chromatin territories within the nuclear space, although cause or consequence is less certain here. The sub-telomeric context likely provides an environment that experiences more frequent breaks, which allowed T. brucei to effectively co-opt and potentially modify a natural response to DNA breaks to achieve efficient antigenic variation. These typically heterochromatic loci also facilitated the massive expansion of the VSG gene family without multi-gene expression. Modifications have been achieved through exploiting minichromosomes to increase the maximum telomeric VSG-count by approximately 10-fold, by expansion of recombinogenic 70 bp repeats flanking VSG genes and, potentially, through BRC-repeat expansions within BRCA2. Clusters of large numbers of silent telomeric VSGs likely now facilitate the homology search and improve access to templates for repair. T. brucei has also co-opted the Pol-I machinery for VSG expression, leading to the formation of a novel extranucleolar, telomere-associated Pol-I compartment. There are a complex variety of chromatin states that could impact transcription, recombination and replication at VSG loci, and it will be important to determine the cis-regulatory sequences, the trans-acting factors and how they interact to drive VSG exclusion and switching. An approach focussed on T. brucei homologues of DNA repair, transcription regulatory and chromatin-associated factors identified in other systems has been fruitful. However, an important goal for the future is to seek factors that play more direct and specific roles in VSG expression control, some of which may represent exploitable drug-targets. Such factors should further illuminate the mechanisms underlying monotelomeric VSG expression and recombination, the processes that make T. brucei such a persistent parasite.
  95 in total

1.  Limitations of silencing at native yeast telomeres.

Authors:  F E Pryde; E J Louis
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

2.  Two pathways of homologous recombination in Trypanosoma brucei.

Authors:  Colin Conway; Chris Proudfoot; Peter Burton; J David Barry; Richard McCulloch
Journal:  Mol Microbiol       Date:  2002-09       Impact factor: 3.501

3.  Probabilistic order in antigenic variation of Trypanosoma brucei.

Authors:  Liam J Morrison; Phelix Majiwa; Andrew F Read; J David Barry
Journal:  Int J Parasitol       Date:  2005-08       Impact factor: 3.981

4.  Differential RNA elongation controls the variant surface glycoprotein gene expression sites of Trypanosoma brucei.

Authors:  L Vanhamme; P Poelvoorde; A Pays; P Tebabi; H Van Xong; E Pays
Journal:  Mol Microbiol       Date:  2000-04       Impact factor: 3.501

5.  Repression of polymerase I-mediated gene expression at Trypanosoma brucei telomeres.

Authors:  Lucy Glover; David Horn
Journal:  EMBO Rep       Date:  2006-01       Impact factor: 8.807

6.  NUP-1 Is a large coiled-coil nucleoskeletal protein in trypanosomes with lamin-like functions.

Authors:  Kelly N DuBois; Sam Alsford; Jennifer M Holden; Johanna Buisson; Michal Swiderski; Jean-Mathieu Bart; Alexander V Ratushny; Yakun Wan; Philippe Bastin; J David Barry; Miguel Navarro; David Horn; John D Aitchison; Michael P Rout; Mark C Field
Journal:  PLoS Biol       Date:  2012-03-27       Impact factor: 8.029

7.  Deletion of a trypanosome telomere leads to loss of silencing and progressive loss of terminal DNA in the absence of cell cycle arrest.

Authors:  Lucy Glover; Sam Alsford; Caroline Beattie; David Horn
Journal:  Nucleic Acids Res       Date:  2007-01-23       Impact factor: 16.971

8.  Evidence for a shared nuclear pore complex architecture that is conserved from the last common eukaryotic ancestor.

Authors:  Jeffrey A DeGrasse; Kelly N DuBois; Damien Devos; T Nicolai Siegel; Andrej Sali; Mark C Field; Michael P Rout; Brian T Chait
Journal:  Mol Cell Proteomics       Date:  2009-06-13       Impact factor: 5.911

9.  Telomeric expression sites are highly conserved in Trypanosoma brucei.

Authors:  Christiane Hertz-Fowler; Luisa M Figueiredo; Michael A Quail; Marion Becker; Andrew Jackson; Nathalie Bason; Karen Brooks; Carol Churcher; Samah Fahkro; Ian Goodhead; Paul Heath; Magdalena Kartvelishvili; Karen Mungall; David Harris; Heidi Hauser; Mandy Sanders; David Saunders; Kathy Seeger; Sarah Sharp; Jesse E Taylor; Danielle Walker; Brian White; Rosanna Young; George A M Cross; Gloria Rudenko; J David Barry; Edward J Louis; Matthew Berriman
Journal:  PLoS One       Date:  2008-10-27       Impact factor: 3.240

10.  Trypanosoma brucei BRCA2 acts in antigenic variation and has undergone a recent expansion in BRC repeat number that is important during homologous recombination.

Authors:  Claire L Hartley; Richard McCulloch
Journal:  Mol Microbiol       Date:  2008-04-22       Impact factor: 3.501

View more
  28 in total

Review 1.  Mono-allelic VSG expression by RNA polymerase I in Trypanosoma brucei: expression site control from both ends?

Authors:  Arthur Günzl; Justin K Kirkham; Tu N Nguyen; Nitika Badjatia; Sung Hee Park
Journal:  Gene       Date:  2014-09-26       Impact factor: 3.688

Review 2.  Mechanisms and principles of homology search during recombination.

Authors:  Jörg Renkawitz; Claudio A Lademann; Stefan Jentsch
Journal:  Nat Rev Mol Cell Biol       Date:  2014-05-14       Impact factor: 94.444

3.  Transcription is initiated on silent variant surface glycoprotein expression sites despite monoallelic expression in Trypanosoma brucei.

Authors:  Ali Kassem; Etienne Pays; Luc Vanhamme
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-02       Impact factor: 11.205

Review 4.  Changing of the guard: How the Lyme disease spirochete subverts the host immune response.

Authors:  George Chaconas; Mildred Castellanos; Theodore B Verhey
Journal:  J Biol Chem       Date:  2019-11-21       Impact factor: 5.157

5.  Quantitative sequencing confirms VSG diversity as central to immune evasion by Trypanosoma brucei.

Authors:  Richard McCulloch; Mark C Field
Journal:  Trends Parasitol       Date:  2015-05-18

Review 6.  The within-host dynamics of African trypanosome infections.

Authors:  Keith R Matthews; Richard McCulloch; Liam J Morrison
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-08-19       Impact factor: 6.237

7.  Specific Cell Targeting Therapy Bypasses Drug Resistance Mechanisms in African Trypanosomiasis.

Authors:  Juan D Unciti-Broceta; José L Arias; José Maceira; Miguel Soriano; Matilde Ortiz-González; José Hernández-Quero; Manuel Muñóz-Torres; Harry P de Koning; Stefan Magez; José A Garcia-Salcedo
Journal:  PLoS Pathog       Date:  2015-06-25       Impact factor: 6.823

8.  SUMOylation by the E3 ligase TbSIZ1/PIAS1 positively regulates VSG expression in Trypanosoma brucei.

Authors:  Diana López-Farfán; Jean-Mathieu Bart; Domingo I Rojas-Barros; Miguel Navarro
Journal:  PLoS Pathog       Date:  2014-12-04       Impact factor: 6.823

Review 9.  Antigenic variation in African trypanosomes.

Authors:  David Horn
Journal:  Mol Biochem Parasitol       Date:  2014-05-22       Impact factor: 1.759

Review 10.  The Trypanosome Flagellar Pocket Collar and Its Ring Forming Protein-TbBILBO1.

Authors:  Doranda Perdomo; Mélanie Bonhivers; Derrick R Robinson
Journal:  Cells       Date:  2016-03-02       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.